Department of Defense April 3, 2017 – Federal Register Recent Federal Regulation Documents

The Military Surface Deployment and Distribution Command (SDDC) will officially have an Open Season thru April 25, 2017. New entrants will be sought for Hawaii and certain Interstate channel combinations where origins/destinations have demonstrated shortage of capacity as determined by SDDC and the Military Services.

The Department of the Navy hereby gives notice of its intent to grant to Epitracker, Inc. a revocable, nonassignable, exclusive license to practice the Government-Owned inventions described in the following U.S. Patent Applications: U.S. Patent Application No. 14/ 591660 (Navy Case No. 103395; U.S. Patent No. 9561206) titled ``Use of Heptadecanoic Acid (C17:0) to Detect Risk of and Treat Hyperferritinemia and Metabolic Syndrome''; U.S. Patent Application No. 14/980304 (Navy Case No. 103856) titled ``Heptadecanoic Acid Supplement to Human Diet''; U.S. Patent Application No. 14/980695 (Navy Case No. 103854) titled ``Method for Detecting Risk Factor for Metabolic Syndrome or Hyperferritinemia''; U.S. Patent Application No. 14/981130 (Navy Case No. 103855) titled ``Method for Treating Metabolic Syndrome''; U.S. Patent Application No. 15/030031 (Navy Case No. 105202) titled ``Compositions and methods for diagnosis and treatment of metabolic syndrome''; U.S. Patent Application No. 15/393771 (Navy Case No. 104602) titled ``Compositions and methods for diagnosis and treatment of anemia''; and U.S. Patent Application No. 15/393799 (Navy Case No. 105245) titled ``Compositions and methods for diagnosis and treatment of inflammation''; as well as any patent issuing thereon, any corresponding foreign patent applications and any foreign patent issuing thereon, and any re-issue, substitution, continuation (but not a continuation-in-part), or division thereof (to the extent that the inventions in the applications are claimed in the parent application on the effective date of the license.)